ACC CardiaCast

“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical information surrounding the challenges that nurses and allied health professionals face every day. In this first set of panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Mary Huntsinger NP, AACC to explore best practices related to atrial fibrillation, including an introduction and overview to the disease.  

In this podcast, alternative models of cardiac rehabilitation (CR) are discussed by Drs. Brown and Tracy, with Dr. Forman serving as moderator. The rationale for the needs for remote and hybrid models of care are presented, as well as the definitions of what these alternative models should be (incorporating all of the key components of the standard of care facility based CR). Specific formats (synchronous and asynchronous) are also explored. Broad conceptual value to patients is described as well as specific experiences at Rush University, where remote and hybrid options are available, as well as site-based cardiac rehabilitation care. The safety and reimbursement is also be reviewed.

In this episode, Drs. Matt Martinez and Theodore Abraham discuss “What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten” for the treatment of hypertrophic cardiomyopathy, and its mechanisms of action.

Are you trying to decide if the Collaborative Maintenance Pathway (CMP) is for you? When it comes to meeting maintenance of certification (MOC) requirements, you have choices! Thousands of your peers have chosen to participate in the CMP. Listen to this interview detailing participants personal experiences and insights.

In this episode, Drs. Matt Martinez and Ahmad Masri discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and mechanisms of action.

In this episode, developed by the ACC Prevention of Cardiovascular Disease Section’s Hypertension Work Group, Dr. Tammy Brady discusses the numerous, often ignored, factors that can lead to inaccurate blood pressure assessment and the degree to which this may affect clinical management. Topics will include cuff size (with a particular focus on Dr. Brady’s recent research), insufficient rest before measuring BP, prescription medications, talking, and presence of staff, among others.

In this episode, developed by the ACC Prevention of Cardiovascular Disease Section’s Hypertension Work Group, Drs. Beth Abramson, Cesar Andres, Nadia Khan, and Karen Tran provide an international perspective on guidelines, care gaps, and ways to close these care gaps.

In this episode, Drs. Matt Martinez and Sara Saberi discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and what sorts of patients are best suited for this treatment.

In this episode, Dr. Michael Shapiro and Dr. Salim Virani discuss the current treatment options for FH, including statin therapy, lifestyle modifications, and non-statin therapy.

In this episode, Dr. Michael Shapiro and Dr. Pam Taub discuss the clinical presentation, natural history, and diagnosis of familial hypercholesterolemia.